Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

ILC1 cells contribute to hair loss in alopecia areata.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Skin bacteria can help wound healing by activating certain immune cells.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Hair follicles prevent NK cell attacks to avoid hair loss.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

DM and AA may share a common cause.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Restoring hair follicle immune privilege may help treat alopecia areata.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

The Siah1 and Siah2 genes are active in mouse skin development and hair growth, especially right after birth.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.